Ailem Rabasa

Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation

Ariel Talavera, Rosmarie Friemann, Silvia Gómez-Puerta et al. · Cancer Research · 2009 · 193 citations

Crystal Structure, Epidermal Growth Factor, Immunology +18

Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells

Jeonghyun Ahn, Tianli Xia, Ailem Rabasa et al. · Cancer Cell · 2018 · 178 citations · Full text

Inflammation, Autoimmune Disease, Dying Cells +14

Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile

Greta Garrido, Ilia Tikhomirov, Ailem Rabasa et al. · Cancer Biology & Therapy · 2011 · 149 citations · Full text

Immunocytochemical Technique, Immunology, Similar Tumor Growth +19

Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody

Greta Garrido, Ailem Rabasa, Belinda Sánchez Pérez et al. · The Journal of Immunology · 2011 · 85 citations · Full text

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

Greta Garrido, Brett Schrand, Ailem Rabasa et al. · Nature Communications · 2019 · 62 citations · Full text